NCT06265389View on ClinicalTrials.gov

Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

June 1, 2025

Conditions
Pentoxifylline as an Adjunct Therapy in the Treatment of Pneumonia
Interventions
DRUG

Pentoxifylline Oral Tablet

50 children with community-acquired pneumonia will receive oral pentoxifylline in tablet form as an adjunct therapy to the usual pneumonia treatment for 5 days and the control group includes 50 children with community-acquired pneumonia with the standard pneumonia treatment.

Trial Locations (1)

37515

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06265389 - Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug | Biotech Hunter | Biotech Hunter